|
REFERENCES
- Adam, D. C. et al. Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nat Med (2020), doi:10.1038/s41591-020-1092-0, PMID:32943787I
- Ali, S. T. et al. Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions. Science 369, 1106-1109 (2020), doi:10.1126/science.abc9004, PMID:32694200I
- Alm, E. et al. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020. Euro Surveill 25 (2020), doi:10.2807/1560-7917.Es.2020.25.32.2001410, PMID:32794443I
- Anna, F. et al. High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris. Eur J Immunol (2020), doi:10.1002/eji.202049058, PMID:33259646I
- Baay, M. et al. SARS-CoV-2: Virology, epidemiology, immunology and vaccine development. Biologicals 66, 35-40 (2020), doi:10.1016/j.biologicals.2020.06.005, PMID:32600951I
- Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370 (2020), doi:10.1126/science.abd4585, PMID:32972996
- Batéjat, C., Grassin, Q., Manuguerra, J. C. & Leclercq, I. Heat inactivation of the severe acute respiratory syndrome coronavirus 2. J Biosaf Biosecur 3, 1-3 (2021), doi:10.1016/j.jobb.2020.12.001, PMID:33521591I
- Bauer, D. C. et al. Interoperable medical data: the missing link for understanding COVID-19. Transbound Emerg Dis (2020), doi:10.1111/tbed.13892, PMID:33095970
- Benetos, A. et al. The Nexus between Telomere Length and Lymphocyte Count in Seniors hospitalized with Covid-19. J Gerontol A Biol Sci Med Sci (2021), doi:10.1093/gerona/glab026, PMID:33528568I
- Bernard Stoecklin, S. et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill 25 (2020), doi:10.2807/1560-7917.Es.2020.25.6.2000094, PMID:32070465I
- Berteloot, L. et al. Arterial abnormalities identified in kidneys transplanted into children during the COVID-19 pandemic. Am J Transplant (2020), doi:10.1111/ajt.16464, PMID:33346946I
- Bielicki, J. A. et al. Monitoring approaches for health-care workers during the COVID-19 pandemic. Lancet Infect Dis 20, e261-e267 (2020), doi:10.1016/s1473-3099(20)30458-8, PMID:32711692I
- Boëlle, P. Y. et al. Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020. Euro Surveill 25 (2020), doi:10.2807/1560-7917.Es.2020.25.14.2000326, PMID:32290901I
- Bonam, S. R., Kaveri, S. V., Sakuntabhai, A., Gilardin, L. & Bayry, J. Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients. Cell Rep Med 1, 100016 (2020), doi:10.1016/j.xcrm.2020.100016, PMID:32562483I
- Bosetti, P. et al. Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France. Euro Surveill 26 (2021), doi:10.2807/1560-7917.Es.2020.26.1.2001978, PMID:33413741I
- Bost, P. et al. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients. Cell (2020), doi:10.1016/j.cell.2020.05.006, PMID:32479746I
- Bouhaddou, M. et al. The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell 182, 685-712.e619 (2020), doi:10.1016/j.cell.2020.06.034, PMID:32645325I
- Bréchot, C. [The pandemic caused by SARS-CoV-2: more than a serious health crisis, a change of time and lessons to be learned urgently]. Med Sci (Paris) (2020), doi:10.1051/medsci/2020245, PMID:33200980I
- Buchrieser, J. et al. Syncytia formation by SARS-CoV-2 infected cells. Embo j, e106267 (2020), doi:10.15252/embj.2020106267, PMID:33051876I
- Cappy, P. et al. No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation. Blood 136, 1888-1891 (2020), doi:10.1182/blood.2020008230, PMID:32871595I
- Cauchemez, S., Kiem, C. T., Paireau, J., Rolland, P. & Fontanet, A. Lockdown impact on COVID-19 epidemics in regions across metropolitan France. Lancet (2020), doi:10.1016/s0140-6736(20)32034-1, PMID:33007219I
- Changeux, J. P., Amoura, Z., Rey, F. A. & Miyara, M. A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications. C R Biol 343, 33-39 (2020), doi:10.5802/crbiol.8, PMID:32720486I
- Cocozza, F. et al. Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus. J Extracell Vesicles 10, e12050 (2020), doi:10.1002/jev2.12050, PMID:33391636I
- Coutard, B., Romette, J. L., Miyauchi, K., Charrel, R. & Prat, C. M. A. The Importance of Biobanking for Response to Pandemics Caused by Emerging Viruses: The European Virus Archive As an Observatory of the Global Response to the Zika Virus and COVID-19 Crisis. Biopreserv Biobank (2020), doi:10.1089/bio.2020.0119, PMID:33181021I
- Crawford, K. H. D. et al. Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays. Viruses 12 (2020), doi:10.3390/v12050513, PMID:32384820I
- Cocozza, F. et al. Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus. J Extracell Vesicles 10, e12050 (2020), doi:10.1002/jev2.12050, PMID:33391636I
- Coutard, B., Romette, J. L., Miyauchi, K., Charrel, R. & Prat, C. M. A. The Importance of Biobanking for Response to Pandemics Caused by Emerging Viruses: The European Virus Archive As an Observatory of the Global Response to the Zika Virus and COVID-19 Crisis. Biopreserv Biobank (2020), doi:10.1089/bio.2020.0119, PMID:33181021I
- Denis, F. et al. Epidemiological Observations on the Association Between Anosmia and COVID-19 Infection: Analysis of Data From a Self-Assessment Web Application. J Med Internet Res 22, e19855 (2020), doi:10.2196/19855, PMID:32496206I
- Du, Z. et al. Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China. Emerg Infect Dis 26, 1049-1052 (2020), doi:10.3201/eid2605.200146, PMID:32053479I
- Du, Z. et al. Serial Interval of COVID-19 among Publicly Reported Confirmed Cases. Emerg Infect Dis 26, 1341-1343 (2020), doi:10.3201/eid2606.200357, PMID:32191173I
- Fafi-Kremer, S. et al. Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France. EBioMedicine, 102915 (2020), doi:10.1016/j.ebiom.2020.102915, PMID:32747185I
- Fertitta, L. et al. Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2. J Eur Acad Dermatol Venereol (2020), doi:10.1111/jdv.16972, PMID:33010072I
- Finlay, B. B. et al. The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome. Proc Natl Acad Sci U S A 118 (2021), doi:10.1073/pnas.2010217118, PMID:33472859I
- Fontanet, A. et al. SARS-CoV-2 variants and ending the COVID-19 pandemic. Lancet (2021), doi:10.1016/s0140-6736(21)00370-6, PMID:33581803I
- Fontanet, A. & Cauchemez, S. COVID-19 herd immunity: where are we? Nat Rev Immunol (2020), doi:10.1038/s41577-020-00451-5, PMID:32908300I
- Fritz, M. et al. High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households. One Health 11, 100192 (2021), doi:10.1016/j.onehlt.2020.100192, PMID:33169106I
- Galmiche, S. et al. Implementing a self-triage web-application for suspected COVID-19 patients' triage: impact on emergency call centers. J Med Internet Res (2020), doi:10.2196/22924, PMID:33147165I
- Gámbaro, F. et al. Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020. Euro Surveill 25 (2020), doi:10.2807/1560-7917.Es.2020.25.26.2001200, PMID:32643599I
- Garfinkel, M., Sansonetti, P. J. & Pulverer, B. Survival of the Wealthiest? Embo j, e107227 (2020), doi:10.15252/embj.2020107227, PMID:33205839I
- Garigliany, M. et al. SARS-CoV-2 Natural Transmission from Human to Cat, Belgium, March 2020. Emerg Infect Dis 26 (2020), doi:10.3201/eid2612.202223, PMID:32788033I
- Garneret, P. et al. Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification. PLoS One 16, e0243712 (2021), doi:10.1371/journal.pone.0243712, PMID:33428641I
- Gordon, D. E. et al. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science (2020), doi:10.1126/science.abe9403, PMID:33060197I
- Gordon, D. E. et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459-468 (2020), doi:10.1038/s41586-020-2286-9, PMID:32353859I
- Goyard, S. et al. A highly sensitive bioluminescent method for measuring allergen-specific IgE in microliter samples. Allergy (2020), doi:10.1111/all.14365, PMID:32407549I
- Grzelak, L. et al. Sex differences in the decline of neutralizing antibodies to SARS-CoV-2. medRxiv, 2020.2011.2012.20230466 (2020), doi:10.1101/2020.11.12.20230466
- Guillier, L. et al. Modelling the inactivation of viruses from the Coronaviridae family in response to temperature and relative humidity in suspensions or surfaces. Appl Environ Microbiol (2020), doi:10.1128/aem.01244-20, PMID:32680860I
- Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718-724 (2020), doi:10.1126/science.abc6027, PMID:32661059I
- Heyerdahl, L. W. et al. Evaluating the motivation of Red Cross Health volunteers in the COVID-19 pandemic: a mixed-methods study protocol. BMJ Open 11, e042579 (2021), doi:10.1136/bmjopen-2020-042579, PMID:33500285I
- Hourdel, V. et al. Rapid Genomic Characterization of SARS-CoV-2 by Direct Amplicon-Based Sequencing Through Comparison of MinION and Illumina iSeq100(TM) System. Front Microbiol 11, 571328 (2020), doi:10.3389/fmicb.2020.571328, PMID:33101244I
- Huang, A. T. et al. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity. Nat Commun 11, 4704 (2020), doi:10.1038/s41467-020-18450-4, PMID:32943637I
- Johansen, M. D. et al. Animal and translational models of SARS-CoV-2 infection and COVID-19. Mucosal Immunol 13, 877-891 (2020), doi:10.1038/s41385-020-00340-z, PMID:32820248I
- Kervevan, J. & Chakrabarti, L. A. Role of CD4+ T Cells in the Control of Viral Infections: Recent Advances and Open Questions. Int J Mol Sci 22 (2021), doi:10.3390/ijms22020523, PMID:33430234I
- Kim, D. K. et al. A Comprehensive, Flexible Collection of SARS-CoV-2 Coding Regions. G3 (Bethesda) (2020), doi:10.1534/g3.120.401554, PMID:32763951I
- Kraemer, M. U. G. et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science 368, 493-497 (2020), doi:10.1126/science.abb4218, PMID:32213647I
- Ku, M. W. et al. Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models. Cell Host Microbe 29, 236-249.e236 (2021), doi:10.1016/j.chom.2020.12.010, PMID:33357418I
- Labadie, T., Batéjat, C., Leclercq, I. & Manuguerra, J. C. Historical Discoveries on Viruses in the Environment and Their Impact on Public Health. Intervirology, 1-16 (2020), doi:10.1159/000511575, PMID:33238280I
- Lecuit, M. Chloroquine and COVID-19, where do we stand? Med Mal Infect 50, 229-230 (2020), doi:10.1016/j.medmal.2020.03.004, PMID:32217166I
- Lemoine, F., Blassel, L., Voznica, J. & Gascuel, O. COVID-Align: Accurate online alignment of hCoV-19 genomes using a profile HMM. Bioinformatics (2020), doi:10.1093/bioinformatics/btaa871, PMID:33045068I
- Lemoine, M. et al. Effect of the COVID-19 pandemic on viral hepatitis services in sub-Saharan Africa. Lancet Gastroenterol Hepatol 5, 966-967 (2020), doi:10.1016/s2468-1253(20)30305-8, PMID:32950107I
- Lescure, F. X. et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis 20, 697-706 (2020), doi:10.1016/s1473-3099(20)30200-0, PMID:32224310I
- Lunz, D., Batt, G. & Ruess, J. To quarantine, or not to quarantine: A theoretical framework for disease control via contact tracing. Epidemics 34, 100428 (2020), doi:10.1016/j.epidem.2020.100428, PMID:33444928I
- Maisonnasse, P. et al. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Nature 585, 584-587 (2020), doi:10.1038/s41586-020-2558-4, PMID:32698191I
- Marot, S. et al. Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers. Nat Commun 12, 844 (2021), doi:10.1038/s41467-021-21111-9, PMID:33558507I
- Mavian, C. et al. Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable. Proc Natl Acad Sci U S A 117, 12522-12523 (2020), doi:10.1073/pnas.2007295117, PMID:32381734I
- Michel, C. J., Mayer, C., Poch, O. & Thompson, J. D. Characterization of accessory genes in coronavirus genomes. Virol J 17, 131 (2020), doi:10.1186/s12985-020-01402-1, PMID:32854725I
- Mögling, R. et al. Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination. Emerg Infect Dis 26, 1944-1946 (2020), doi:10.3201/eid2608.201843, PMID:32433015I
- O'Driscoll, M. et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature (2020), doi:10.1038/s41586-020-2918-0, PMID:33137809I
- Ostaszewski, M. et al. COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms. Sci Data 7, 136 (2020), doi:10.1038/s41597-020-0477-8, PMID:32371892I
- Piccoli, L. et al. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology. Cell 183, 1024-1042.e1021 (2020), doi:10.1016/j.cell.2020.09.037, PMID:32991844I
- Pinto, D. et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature (2020), doi:10.1038/s41586-020-2349-y, PMID:32422645I
- Plaze, M. et al. Repurposing chlorpromazine to treat COVID-19: The reCoVery study. Encephale 46, 169-172 (2020), doi:10.1016/j.encep.2020.05.006, PMID:32425222I
- Plaze, M. et al. Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine. Int J Antimicrob Agents, 106274 (2020), doi:10.1016/j.ijantimicag.2020.106274, PMID:33387629I
- Roederer, T. et al. Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study. Lancet Public Health (2021), doi:10.1016/s2468-2667(21)00001-3, PMID:33556328I
- Rosado, J. et al. Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study. Lancet Microbe 2, e60-e69 (2021), doi:10.1016/s2666-5247(20)30197-x, PMID:33521709I
- Sa Ribero, M., Jouvenet, N., Dreux, M. & Nisole, S. Interplay between SARS-CoV-2 and the type I interferon response. PLoS Pathog 16, e1008737 (2020), doi:10.1371/journal.ppat.1008737, PMID:32726355I
- Sailleau, C. et al. First detection and genome sequencing of SARS-CoV-2 in an infected cat in France. Transbound Emerg Dis (2020), doi:10.1111/tbed.13659, PMID:32500944I
- Salje, H. et al. Estimating the burden of SARS-CoV-2 in France. Science 369, 208-211 (2020), doi:10.1126/science.abc3517, PMID:32404476I
- Sansonetti, P. J. COVID-19, chronicle of an expected pandemic. EMBO Mol Med 12, e12463 (2020), doi:10.15252/emmm.202012463, PMID:32259394I
- Sarkar, M. & Saha, S. Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies. PLoS One 15, e0237300 (2020), doi:10.1371/journal.pone.0237300, PMID:32785274I
- Schoof, M. et al. An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike. Science (2020), doi:10.1126/science.abe3255, PMID:33154106I
- Silvin, A. et al. Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19. Cell 182, 1401-1418.e1418 (2020), doi:10.1016/j.cell.2020.08.002, PMID:32810439I
- Smadja, D. M. et al. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis 23, 611-620 (2020), doi:10.1007/s10456-020-09730-0, PMID:32458111I
- Smith, D. R. M. et al. Optimizing COVID-19 surveillance in long-term care facilities: a modelling study. BMC Med 18, 386 (2020), doi:10.1186/s12916-020-01866-6, PMID:33287821I
- Sokal, A. et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell (2021), doi:10.1016/j.cell.2021.01.050, PMID:33571429I
- Spiteri, G. et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro Surveill 25 (2020), doi:10.2807/1560-7917.Es.2020.25.9.2000178, PMID:32156327I
- Sterlin, D. & Gorochov, G. When Therapeutic IgA Antibodies Might Come of Age. Pharmacology, 1-11 (2020), doi:10.1159/000510251, PMID:32950975I
- Tekpinar, M. & Yildirim, A. Impact of dimerization and N3 binding on molecular dynamics of SARS-CoV and SARS-CoV-2 main proteases. J Biomol Struct Dyn, 1-12 (2021), doi:10.1080/07391102.2021.1880481, PMID:33525993I
- Temime, L. et al. A Conceptual Discussion about R0 of SARS-COV-2 in Healthcare Settings. Clin Infect Dis (2020), doi:10.1093/cid/ciaa682, PMID:32473007I
- Temmam, S. et al. Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus. One Health, 100164 (2020), doi:10.1016/j.onehlt.2020.100164, PMID:32904469I
- Tortorici, M. A. et al. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science (2020), doi:10.1126/science.abe3354, PMID:32972994I
- Tubiana, S. et al. High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in in-hospital workers - the CoV-CONTACT cohort. J Infect (2021), doi:10.1016/j.jinf.2021.01.026, PMID:33545165I
- van der Werf, S. & Peltekian, C. Facing challenges with the novel coronavirus SARS-CoV-2 outbreak. Virologie (Montrouge) 24, e12-15 (2020), doi:10.1684/vir.2020.0826, PMID:32186279I
- Veyer, D. et al. Highly sensitive quantification of plasma SARS-CoV-2 RNA shelds light on its potential clinical value. Clin Infect Dis (2020), doi:10.1093/cid/ciaa1196, PMID:32803231I
- Vieira, M. et al. Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on "Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome" by Quartuccio et al. Joint Bone Spine. 2020;87:191-93. Joint Bone Spine (2020), doi:10.1016/j.jbspin.2020.09.006, PMID:32950702I
- Walls, A. C. et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell 181, 281-292 e286 (2020), doi:10.1016/j.cell.2020.02.058, PMID:32155444I
- White, K. M. et al. Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. Science (2021), doi:10.1126/science.abf4058, PMID:33495306I
- Xu, B. et al. Epidemiological data from the COVID-19 outbreak, real-time case information. Sci Data 7, 106 (2020), doi:10.1038/s41597-020-0448-0, PMID:32210236I
- Xu, X. K. et al. Reconstruction of Transmission Pairs for novel Coronavirus Disease 2019 (COVID-19) in mainland China: Estimation of Super-spreading Events, Serial Interval, and Hazard of Infection. Clin Infect Dis (2020), doi:10.1093/cid/ciaa790, PMID:32556265I
- Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370 (2020), doi:10.1126/science.abd4570, PMID:32972995I
- Zhukova, A. et al. Origin, evolution and global spread of SARS-CoV-2. C R Biol (2020), doi:10.5802/crbiol.29, PMID:33274614I